Omega Healthcare Investors Future Growth
Future criteria checks 0/6
Omega Healthcare Investors is forecast to grow earnings and revenue by 9.6% and 0.1% per annum respectively. EPS is expected to grow by 6.8% per annum. Return on equity is forecast to be 11.5% in 3 years.
Key information
9.6%
Earnings growth rate
6.8%
EPS growth rate
Health Care REITs earnings growth | 24.4% |
Revenue growth rate | 0.1% |
Future return on equity | 11.5% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 955 | 489 | 893 | N/A | 7 |
12/31/2025 | 919 | 446 | 858 | N/A | 9 |
12/31/2024 | 851 | 408 | 835 | N/A | 9 |
9/30/2024 | 1,011 | 348 | 685 | 685 | N/A |
6/30/2024 | 977 | 328 | 672 | 672 | N/A |
3/31/2024 | 975 | 274 | 658 | 658 | N/A |
12/31/2023 | 950 | 242 | 618 | 618 | N/A |
9/30/2023 | 855 | 233 | 606 | 606 | N/A |
6/30/2023 | 853 | 244 | 602 | 602 | N/A |
3/31/2023 | 847 | 273 | 605 | 605 | N/A |
12/31/2022 | 878 | 427 | 626 | 626 | N/A |
9/30/2022 | 983 | 415 | 629 | 629 | N/A |
6/30/2022 | 1,026 | 451 | 649 | 649 | N/A |
3/31/2022 | 1,038 | 446 | 678 | 678 | N/A |
12/31/2021 | 1,063 | 417 | 722 | 722 | N/A |
9/30/2021 | 1,077 | 445 | 763 | 763 | N/A |
6/30/2021 | 914 | 215 | 757 | 757 | N/A |
3/31/2021 | 913 | 229 | 745 | 745 | N/A |
12/31/2020 | 892 | 159 | 708 | 708 | N/A |
9/30/2020 | 875 | 157 | 659 | 659 | N/A |
6/30/2020 | 989 | 388 | 618 | 618 | N/A |
3/31/2020 | 958 | 361 | 583 | 583 | N/A |
12/31/2019 | 929 | 341 | 554 | 554 | N/A |
9/30/2019 | 902 | 344 | 557 | 557 | N/A |
6/30/2019 | 891 | 262 | 548 | 548 | N/A |
3/31/2019 | 885 | 267 | 557 | 557 | N/A |
12/31/2018 | 882 | 282 | 499 | 499 | N/A |
9/30/2018 | 883 | 282 | 499 | 499 | N/A |
6/30/2018 | 881 | 93 | N/A | 531 | N/A |
3/31/2018 | 897 | 80 | N/A | 518 | N/A |
12/31/2017 | 908 | 100 | N/A | 578 | N/A |
9/30/2017 | 922 | 162 | N/A | 595 | N/A |
6/30/2017 | 927 | 373 | N/A | 602 | N/A |
3/31/2017 | 920 | 415 | N/A | 610 | N/A |
12/31/2016 | 901 | 366 | N/A | 625 | N/A |
9/30/2016 | 877 | 303 | N/A | 598 | N/A |
6/30/2016 | 854 | 304 | N/A | 558 | N/A |
3/31/2016 | 823 | 237 | N/A | 488 | N/A |
12/31/2015 | 744 | 225 | N/A | 449 | N/A |
9/30/2015 | 664 | 221 | N/A | 401 | N/A |
6/30/2015 | 593 | 203 | N/A | 364 | N/A |
3/31/2015 | 517 | 209 | N/A | 363 | N/A |
12/31/2014 | 505 | 221 | N/A | 338 | N/A |
9/30/2014 | 485 | 212 | N/A | 339 | N/A |
6/30/2014 | 457 | 188 | N/A | 325 | N/A |
3/31/2014 | 438 | 190 | N/A | 300 | N/A |
12/31/2013 | 419 | 173 | N/A | 280 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: O2HI34's forecast earnings growth (9.6% per year) is below the savings rate (10.4%).
Earnings vs Market: O2HI34's earnings (9.6% per year) are forecast to grow slower than the BR market (12.7% per year).
High Growth Earnings: O2HI34's earnings are forecast to grow, but not significantly.
Revenue vs Market: O2HI34's revenue (0.1% per year) is forecast to grow slower than the BR market (7.4% per year).
High Growth Revenue: O2HI34's revenue (0.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: O2HI34's Return on Equity is forecast to be low in 3 years time (11.5%).